Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

By Bertolotti-Ciarlet A.   Ciarlet M.   Crawford S.E.   Conner M.E.   Estes M.K.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3885-3900

Elsevier

Access to resources Recommend Favorite

Secondary vaccination with vaccinia virus recombinants: role of residual virulence of recombinants and immunogenicity of extrinsic antigens

By Kutinova L.   Ludvkova V.   Nemeckova S.   Hainz P.   Simonova V.   Vonka V.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1186-1192

Elsevier

Access to resources Recommend Favorite

Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees

By Chengalvala M.V.   Bhat B.M.   Bhat R.A.   Dheer S.K.   Lubeck M.D.   Purcell R.H.   Murthy K.K.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 335-339

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite